Identification of germline cancer predisposition variants during clinical ctDNA testing

Abstract Next-generation sequencing of circulating tumor DNA (ctDNA) is a non-invasive method to guide therapy selection for cancer patients. ctDNA variant allele frequency (VAF) is commonly reported and may aid in discerning whether a variant is germline or somatic. We report on the fidelity of VAF...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Leigh Anne Stout, Nawal Kassem, Cynthia Hunter, Santosh Philips, Milan Radovich, Bryan P. Schneider
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0cc58bca3e134f00802d49538b3886c5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares